Calisha Myers

Articles by Calisha Myers

Juvaris completes $25M close of series B

Adjuvant vaccines developer Juvaris BioTherapeutics has completed the first close of a Series B round. The Burlingame, CA-based company says it will use the capital to advance its technology platform

MedImmune: Vaccine ready to go at month's end

MedImmune, which began clinical trials for its swine flu vaccine last month, says the inhaled vaccine could be ready by the end of September. The AstraZeneca subsidiary is now waiting on the FDA to

Vaccine for Hendra virus 15 years, $1B away

A human vaccine to guard against the Hendra virus, which recently caused the death of an Australian veterinarian, may be 15 years and one billion dollars away, the renowned scientist Ian Frazer tells

No H1N1 vaccine contracts for India

Some are questioning India's response to the swine flu pandemic. While many countries have been buying up vaccines before they have even been produced, Indian officials continue to watch from the

Swine flu news roundup

There's new information on swine flu and the companies racing to produce vaccines everyday. Here's a roundup of recent announcements. GlaxoSmithKline announced that in the past two weeks it has

Inovio's shares boosted on positive H1N1 trials

After a year of trading below $1, shares of Inovio Biomedical soared to $3.18 yesterday. The revival was sparked by the San Diego based company's announcement of positive results from animal studies

MedImmune races ahead to deliver on H1N1 contracts

The U.S. has ordered 195 million doses of swine flu vaccine from five different developers. While many companies are reportedly having trouble growing enough of the H1N1 virus to produce ample doses

CSL begins first human trials of H1N1 vaccine

The first human trial of an H1N1 vaccine began Wednesday. Melbourne, Australia-based developer CSL has launched a human trial of its experimental H1N1 vaccine in partnership with the clinical

GSK begins phase III global trial for malaria vax

GlaxoSmithKline is pushing forward with the final stages of pre-approval development of its malaria vaccine candidate Mosquirix. Scientists began injecting 1,200 infants and children involved in its

Swine flu continues to spread in US

The U.S. has experienced the second highest rate of swine flu infection with 66 confirmed cases as of Wednesday morning. The virus has reached New York, Kansas, Ohio, Texas, Indiana and California.